Axa Venture Partners was among the limited partners that have helped the deep tech-focused venture firm raise $59.4m for its second fund.

The universities of Edinburgh, Manchester, Glasgow and Aberdeen have all contributed to Epidarex’s latest fund, which will invest in life sciences spinouts.

The nutrition and biotechnology company is accepting applications for its five-month Ajinomoto Group Accelerator initiative, which is scheduled to begin in December.

Uniseed has entered a co-investment pact with BioCurate, a drug discovery fund for early-stage University of Melbourne and Monash University research.

The scheme will involve increased investment in black-led companies and capital firms as well as the formation of an accelerator for black entrepreneurs.

Internet and telecommunications software producer Ultrapower Software's corporate venturing unit has closed a $19.4m fund that featured external limited partners.

The social media operator is seeking a head of investments for its NPE subsidiary who will reportedly work with Gradient Ventures alumnus Shabih Rizvi.

UCeed will target four to eight healthcare projects with a focus on child medicine, investing up to $220,000 per transaction.

The new energy-focused fund has added Air Liquide's corporate venturing unit to limited partners including CMA CGM and Total Carbon Neutrality Ventures.

Life sciences venture firm 4Bio Capital has secured the biopharmaceutical company as the first strategic backer for its second fund.